Serum and ascites neutralizing antibodies in ovarian cancer patients treated with intraperitoneal adenoviral gene therapy.
Hemminki
Akseli
A
Division of Human Gene Therapy, Department of Medicine, Gene Therapy Center, University of Alabama at Birmingham, Birmingham, AL 35294, USA. akseli@uab.edu
Wang
Minghui
M
Desmond
Renee A
RA
Strong
Theresa V
TV
Alvarez
Ronald D
RD
Curiel
David T
DT
D000256:Adenoviridae / Q000276:immunology; D000914:Antibodies, Viral / Q000097:blood* / Q000235:genetics / Q000276:immunology; D001201:Ascites / Q000276:immunology*; D005260:Female; D015316:Genetic Therapy; D005822:Genetic Vectors; D006801:Humans; D010051:Ovarian Neoplasms / Q000097:blood / Q000235:genetics / Q000276:immunology* / Q000628:therapy*
D000914:Antibodies, Viral